HERCRNA

Welcome to the Brand page for “HERCRNA”, which is offered here for Vaccines; oral vaccines; modified cells for medical or clinical use; pharmaceuticals; oral vaccine preparations; pharmaceutical products for the treatment of infectious diseases; recombinant yeast-based pharmaceutical products; yeast-based oral vaccines; pharmaceutical preparations, a drug delivery system comprising yeast-based oral vaccines; pharmaceutical products, yeast-based oral vaccines; biological and pharmaceutical preparations, recombinant yeast for medical use; medical, biological, and pharmaceutical preparations for medical use, preparations containing messenger rna for preventing infection, disease, or disorders; medical, biological, and pharmaceutical preparations for medical use, preparations containing messenger rna for treating infection, disease, or disorders; mrna-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ prevention of infection, disease, or disorders; mrna-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ treatment of infection, disease, or disorders;.

Its status is currently believed to be active. Its class is unavailable. “HERCRNA” is believed to be currently owned by “Esperovax, Inc.”